Connect with us


Mazzanti manufacturer launches a STO after three equity crowdfunding campaigns

The campaign launched by Mazzanti has a duration of 60 days and has a minimum target of $964,000 (€800,000) and a maximum target of $1.21 million (€1 million) (999,999 to be precise) and is allowed to invest both in Euros and in certain cryptocurrencies: Bitcoin (BTC), or USD Tether (USDT, a stable coin based on the dollar) and Liquid Bitcoin (L-BTC).



Mazzanti’s race to raise funds using the tools made available by the international fintech sector continues unabated. After the three equity crowdfunding campaigns on Crowdfundme in Italy, Seedrs in the UK, and Fundedbyme in Sweden, the Tuscan producer of handcrafted hypercars launched on Thursday, February 25th, a Security Token Offering (STO) on the Luxembourg platform Stockr.

The operation consists in the issue of tokens (MZZ) with a nominal value of $1.21 (€1) that represent the right to receive pro-rata 50% of the sale value (net of taxes) of one example of the Evantra Millecavalli Racing, the new hypercar produced by Mazzanti. The tokens are issued by the corporate vehicle Mobility Venture One (Lux) S.C.S, specifically set up by Mazzanti Automobili Srl.

Read more details about Mazzanti and find the latest business news in the world with our companion app Born2Invest.

MZZs are not cryptocurrencies

They are financial instruments, “securities” within the meaning of MiFID II, that are issued, traded, and held with proof of ownership registered on the Liquid Network, built as a sidechain of the Bitcoin blockchain. Investors can keep their MZZ on Green Wallet by simply registering it on STOKR. MZZs are registered securities (registered securities) with a preferential right to share in the proceeds from the sale price of a Millecavalli under Luxembourg law. The offer is expected to make use of Article 1 (3) of the Prospectus Regulation (EU) 2017.

The campaign has a duration of 60 days and has a minimum target of $964,000 (€800,000) and a maximum target of $1.21 million (€1 million (999,999 to be precise) and is allowed to invest both in Euros and in certain cryptocurrencies: Bitcoin (BTC), or USD Tether (USDT, a stable coin based on the dollar) and Liquid Bitcoin (L-BTC).

Through this offering, the company intends to raise the working capital needed for the production of its latest prototype, the “Millecavalli R” a unique racing version of the iconic Millecavalli model.

Founder, Luca Mazzanti said, “Mazzanti Automobili’s STO represents a new era for premium luxury car brands to finance and develop their capital. STO enables the creation of a new, more innovative and sexy supercar model, thus maintaining a strategic advantage over competitors. STO shares 50% of its revenues with our tokenists. This means that Mazzanti Automobili intends to engage new investors who are passionate and ready for an exciting global growth path. Investors can enjoy the expansion of the brand, the building of innovative hypercars, the development of sustainable “green” growth and, finally, the profits and satisfying returns on every capital invested.”

Mazzanti Automobili is an Italian automotive company that produces hand-built high-performance hypercars

The “journey” started in 2002 in Pontedera, Italy, with founder Luca Mazzanti, who created a restoration and development workshop for sports supercars before moving into new model production over the past 10 years.

From the beginning, the company focused its energies on the study, design and technical research for the Evantra, 771 and Millecavalli hypercars, selecting suppliers and attracting the best automotive expertise. To date, Mazzanti has produced 15 highly sought-after cars purchased by both track enthusiasts and one-off collectors.

The company launched three equity crowdfunding rounds between 2020 and early 2021, raising a total of just over $1.21 million (€1 million).


(Featured image by Evantra Millecavalli CC BY-SA 4.0 via Wikicommons)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Daphne Freeman has worked in the crowdfunding and impact investing industry for the past few years, gaining experience in marketing, and connecting businesses and entrepreneurs in need with the right investors. As a seasoned grant writer as well as financial market journalist, she is passionate about making a social impact in the world. A free spirit, Daphne also enjoys writing and exploring topics of interest, currently CBD, health and beauty, and social media influencers.